ManyMangoes
Pharmad-Mand Q1 2024 Proposal
Project Overview
Phase 1: Cost-Friendly, Huge Reach
Objective: Harness LinkedIn to target and engage Consultants within Biotech and Biopharma sectors across the USA, Canada, and the EU, aiming to yield 30-100 quality leads monthly.
Scope: Entails sourcing precise contacts, deep profile analysis, honing targeting strategies for key demographics, crafting tailored content, LinkedIn presence enhancement, and initiating strategic prospect interactions.
Campaign Strategy
Target Audience: Consultants in Biotech and Biopharma across the USA, Canada, and the EU, especially those showing affinity towards Cell & Gene Therapy solutions in line with their competencies and professional foci.
Key Messages: Customised to underscore the distinct advantages of targeted Cell & Gene Therapy solutions, meeting the nuanced demands and challenges faced by this specialist consultant demographic.
Content Strategy: Forge and execute a content plan integrating bespoke connection requests, InMails, emails, event-related content, and phone scripts, all constructed to engage effectively with the defined ICP.
Deliverables
Roles & Responsibilities
ManyMangoes team will be responsible for strategy development, content creation, and day-to-day execution of the campaign.
PharmaD-mand team will provide product expertise, approve content, BDC calling support, and assist in defining the ICP.
Performance Metrics
KPIs: Engagement rate, response rate, lead generation rate, and conversion rate.
Monitoring and Reporting: Weekly and quarterly reports on campaign performance, with insights and recommendations for optimisation.
9-Week Pilot Summary
Phase 1: Cost-Friendly, Huge Reach
£3,150
Read More
Campaign Notes